P3 Health Partners (PIIIW) Competitors $0.0090 0.00 (-4.26%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrends PIIIW vs. ACONW, AONC, DHACW, CORBF, LFMDP, OTRKP, TALKW, TOIIW, NTRA, and FMSShould you be buying P3 Health Partners stock or one of its competitors? The main competitors of P3 Health Partners include Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), Global Cord Blood (CORBF), LifeMD (LFMDP), Ontrak (OTRKP), Talkspace (TALKW), Oncology Institute (TOIIW), Natera (NTRA), and Fresenius Medical Care (FMS). These companies are all part of the "healthcare" industry. P3 Health Partners vs. Aclarion American Oncology Network Digital Health Acquisition Global Cord Blood LifeMD Ontrak Talkspace Oncology Institute Natera Fresenius Medical Care P3 Health Partners (NASDAQ:PIIIW) and Aclarion (NASDAQ:ACONW) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, community ranking, dividends, analyst recommendations, profitability, earnings, valuation and risk. Is PIIIW or ACONW more profitable? Company Net Margins Return on Equity Return on Assets P3 Health PartnersN/A N/A N/A Aclarion N/A N/A N/A Does the media favor PIIIW or ACONW? In the previous week, P3 Health Partners had 1 more articles in the media than Aclarion. MarketBeat recorded 1 mentions for P3 Health Partners and 0 mentions for Aclarion. P3 Health Partners' average media sentiment score of 0.64 beat Aclarion's score of 0.00 indicating that P3 Health Partners is being referred to more favorably in the media. Company Overall Sentiment P3 Health Partners Positive Aclarion Neutral Does the MarketBeat Community prefer PIIIW or ACONW? P3 Health Partners and Aclarion both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformP3 Health PartnersN/AN/AAclarionN/AN/A Which has higher earnings & valuation, PIIIW or ACONW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioP3 Health Partners$1.48BN/AN/AN/AN/AAclarion$49.29KN/AN/AN/AN/A SummaryP3 Health Partners beats Aclarion on 3 of the 3 factors compared between the two stocks. Ad ProsperityPubCrypto’s hidden gem + greatest crypto bull run in history = $$$?You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.Click Here to get the full details about Crypto’s Hidden Gem Get P3 Health Partners News Delivered to You Automatically Sign up to receive the latest news and ratings for PIIIW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PIIIW vs. The Competition Export to ExcelMetricP3 Health PartnersMedical Care Facilities IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$1.45B$5.14B$9.08BDividend YieldN/A3.79%5.09%4.23%P/E RatioN/A209.5590.1317.19Price / SalesN/A54.381,116.25117.05Price / CashN/A13.4543.1037.85Price / BookN/A2.314.784.78Net IncomeN/A$52.03M$120.31M$225.60M7 Day PerformanceN/A-1.00%-1.92%-1.23%1 Month PerformanceN/A1.99%13.65%0.46%1 Year PerformanceN/A12.94%28.34%15.24% P3 Health Partners Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PIIIWP3 Health PartnersN/A$0.01-4.3%N/AN/A$0.00$1.48B0.00500Positive NewsGap UpACONWAclarionN/A$0.03-17.9%N/A-36.1%$0.00$49,289.000.007Positive NewsGap DownAONCAmerican Oncology NetworkN/A$4.68+2.7%N/A-22.5%$0.00$1.34B0.001,520News CoverageDHACWDigital Health AcquisitionN/A$0.06flatN/AN/A$0.00N/A0.00N/ACORBFGlobal Cord BloodN/A$1.26flatN/A+15.4%$0.00$196.12M0.001,202High Trading VolumeLFMDPLifeMDN/A$22.500.0%N/A+17.1%$0.00$193.06M0.00230OTRKPOntrakN/A$0.28-3.5%N/A-57.6%$0.00$10.84M0.00250Gap DownTALKWTalkspaceN/A$0.12-14.2%N/A+7.1%$0.00$181.29M0.00500Gap DownTOIIWOncology InstituteN/A$0.01flatN/A-95.0%$0.00$378.93M0.00660Positive NewsNTRANatera1.8947 of 5 stars$170.80+2.6%$152.67-10.6%+168.5%$22.55B$1.53B-97.053,293Positive NewsGap DownFMSFresenius Medical Care3.4994 of 5 stars$23.82+0.7%$24.30+2.0%+8.6%$13.98B$19.24B19.791,358News CoveragePositive News Related Companies and Tools Related Companies Aclarion Competitors American Oncology Network Competitors Digital Health Acquisition Competitors Global Cord Blood Competitors LifeMD Competitors Ontrak Competitors Talkspace Competitors Oncology Institute Competitors Natera Competitors Fresenius Medical Care Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PIIIW) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding P3 Health Partners Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share P3 Health Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
